Suboxone Treatment: How to Get Buprenorphine

If you have been circling the idea of getting on Suboxone, here is the part nobody tells you: it has never been easier to start. The special federal waiver that used to gate buprenorphine prescribing is gone, patient limits are gone, and telemedicine appointments count. What is left is the ordinary step that has always been the hard one — deciding tonight that you want off the rollercoaster, and making one call.

If someone is unresponsive or breathing slowly, call 911 and give naloxone if you have it. For a mental health or substance use crisis, call or text 988.

How do you get Suboxone treatment?

It depends on what you need and where you live. The typical path is a medical appointment — in person or by telemedicine — where a prescriber confirms opioid use disorder, waits for you to be in mild-to-moderate withdrawal, and starts you on a low dose that is titrated up over a few days. Any practitioner with a standard DEA registration and Schedule III authority can prescribe buprenorphine under federal law, subject to state rules. Some people prefer a certified opioid treatment program with daily visits at first; others do well with an office prescriber or telehealth and monthly refills. Your first move: search FindTreatment.gov for a buprenorphine provider near you, or use the steps at the bottom of this page.

What Suboxone actually is

Suboxone sublingual film combines two medicines, per FDA labeling:

• Buprenorphine — a partial opioid agonist. It occupies the same mu-opioid receptors that oxycodone or heroin do, but with a weaker, ceiling-limited effect. That calms cravings and withdrawal without a full high, and it lowers overdose risk compared with full agonists.
• Naloxone — an opioid antagonist that does nothing when the film dissolves under the tongue, but produces withdrawal if the film is dissolved and injected. Its job is to deter misuse.

The film is indicated for treatment of opioid dependence as part of a complete plan including counseling and psychosocial support. It comes in four strengths, from 2 mg/0.5 mg up to 12 mg/3 mg, and the usual maintenance target is 16 mg/4 mg once daily. It is a Schedule III controlled substance, approved since 2002.

Who can prescribe it — and how telemedicine fits

This is where the landscape changed. Three facts, all sourced:

1. No waiver needed. SAMHSA states that Section 1262 of the Consolidated Appropriations Act of 2023 removed the federal requirement for a DATA waiver (Notice of Intent) to prescribe buprenorphine for opioid use disorder. DEA confirmed there are no longer any patient caps, and prescriptions only need a standard DEA number.
2. State law still counts. SAMHSA notes federal law does not override state requirements, so some states add their own training or supervision rules.
3. Telemedicine is authorized. 21 CFR 1307.41, in effect through December 31, 2026, lets DEA-registered practitioners prescribe Schedule III-V controlled substances via telemedicine without a prior in-person evaluation. DEA's extension announcement also notes a finalized rule specifically expanding buprenorphine treatment via telemedicine encounter. Expect this area to keep evolving; a telehealth provider will tell you what currently applies in your state.

In practice that means a person in a rural county with no addiction psychiatrist for a hundred miles can still get a buprenorphine induction this week.

How starting works: the withdrawal-first rule

You do not take Suboxone while full opioids are still active in your system. FDA labeling is explicit: induction should begin when objective and clear signs of withdrawal are evident, because buprenorphine can knock stronger opioids off their receptors and cause precipitated withdrawal — a sudden, severe onset of withdrawal symptoms. For people dependent on short-acting opioids, labeling describes starting with up to 8 mg/2 mg in divided doses on day one and up to 16 mg/4 mg on day two. People dependent on methadone or other long-acting opioids need a different, slower induction onto buprenorphine monotherapy.

A prescriber manages this; you should not self-start. Typical first-day advice is to wait until you are moderately uncomfortable — usually 12 to 24 hours after the last short-acting opioid — before the first film.

What treatment looks like after induction

• Daily dosing, a film dissolved under the tongue or against the cheek. Do not cut, chew, or swallow it.
• Counseling and psychosocial support alongside medication, which the label calls part of a complete plan — though SAMHSA notes counseling is strongly recommended, not federally required to receive the medication.
• Naloxone on hand. The label says prescribers should strongly consider prescribing or recommending an overdose reversal agent at initiation and renewal, because relapse happens and relapse after tolerance drops is the deadly combination.
• Careful stopping. If you ever want to come off, labeling calls for a gradual taper with your provider, not an abrupt stop; buprenorphine produces its own milder, delayed physical dependence when used chronically.

Two safety notes from the label: combining Suboxone with benzodiazepines, alcohol, or other CNS depressants can be fatal, and it is not an analgesic — there have been reported deaths of opioid-naive individuals who took even a 2 mg dose.

Medication, not a swap

The question comes up in every waiting room: am I just addicted to Suboxone now? The FDA patient labeling answers it: physical dependence is not the same as drug addiction. Being stabilized on a prescribed partial agonist that you take as directed, that blocks the worst of cravings, and that lets you work, parent, and sleep — that is treatment. People in buprenorphine treatment keep jobs and driver's licenses. The choice between medication and abstinence-only attempts is yours, but the evidence favors medication for staying alive and staying in recovery.

Steps you can take tonight

1. Search FindTreatment.gov by ZIP code; facilities offering buprenorphine are searchable there.
2. Call SAMHSA's National Helpline at 1-800-662-HELP (4357) — free, confidential, 24/7 — and ask specifically for buprenorphine providers near you.
3. Call or text (800) 653-9376 to talk through options, telehealth availability in your state, and whether your insurance covers medication visits.

The referral call is free, and the service is paid for by treatment providers. Withdrawal tonight is temporary; the dose you take tomorrow morning can be the first day of a different year.

Call 911 in a medical emergency. Call or text 988 for a mental health or substance use crisis. City-level guides in this series: Suboxone treatment in Daytona Beach, Florida, Suboxone treatment in Fort Lauderdale, Florida, Suboxone treatment in Fort Myers, Florida, Suboxone treatment in Gainesville, Florida, Suboxone treatment in Jacksonville, Florida, Suboxone treatment in Lakeland, Florida, Suboxone treatment in Miami, Florida, Suboxone treatment in Ocala, Florida, Suboxone treatment in Orlando, Florida, Suboxone treatment in Pensacola, Florida, Suboxone treatment in Sarasota, Florida, Suboxone treatment in St Petersburg, Florida, Suboxone treatment in Tallahassee, Florida, Suboxone treatment in Tampa, Florida, Suboxone treatment in West Palm Beach, Florida, Suboxone treatment in Ashland, Kentucky, Suboxone treatment in Bowling Green, Kentucky, Suboxone treatment in Covington, Kentucky, Suboxone treatment in Danville, Kentucky, Suboxone treatment in Elizabethtown, Kentucky, Suboxone treatment in Frankfort, Kentucky.

Frequently asked questions